Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

What Have We Learned From the Osaka Study?

Uchino M, Uchino Y, Kawashima M, Yokoi N, Tsubota K.

Cornea. 2018 Sep 6. doi: 10.1097/ICO.0000000000001731. [Epub ahead of print]

PMID:
30211748
2.

Quality of life measures and health utility values among dry eye subgroups.

Shigeyasu C, Yamada M, Kawashima M, Suwaki K, Uchino M, Hiratsuka Y, Yokoi N, Tsubota K; DECS-J study group.

Health Qual Life Outcomes. 2018 Aug 31;16(1):170. doi: 10.1186/s12955-018-0999-3.

3.

Biopsy of recurrent nasolacrimal duct obstruction using sheath-guided dacryoendoscopy.

Ueda K, Watanabe A, Yokoi N, Sugimoto M, Fukuoka H, Shinomiya K, Kinoshita S, Rajak S, Selva D.

Orbit. 2018 Aug 24:1-6. doi: 10.1080/01676830.2018.1513536. [Epub ahead of print]

PMID:
30142018
4.

Effects of Lipid Saturation on the Surface Properties of Human Meibum Films.

Nencheva Y, Ramasubramanian A, Eftimov P, Yokoi N, Borchman D, Georgiev GA.

Int J Mol Sci. 2018 Jul 28;19(8). pii: E2209. doi: 10.3390/ijms19082209.

5.

The evaluation of dry eye mobile apps for screening of dry eye disease and educational tear event in Japan.

Uchino M, Kawashima M, Uchino Y, Suzuki N, Mitamura H, Mizuno M, Hori Y, Yokoi N, Tsubota K.

Ocul Surf. 2018 Jun 5. pii: S1542-0124(17)30370-1. doi: 10.1016/j.jtos.2018.06.002. [Epub ahead of print]

PMID:
29883737
6.

Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.

Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, Hayashi Y, Inuzuka T, Shimohata T.

J Neuroimmunol. 2018 Jun 15;319:63-67. doi: 10.1016/j.jneuroim.2018.04.001. Epub 2018 Apr 4.

PMID:
29685291
7.

Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22.

Yamagata A, Miyazaki Y, Yokoi N, Shigematsu H, Sato Y, Goto-Ito S, Maeda A, Goto T, Sanbo M, Hirabayashi M, Shirouzu M, Fukata Y, Fukata M, Fukai S.

Nat Commun. 2018 Apr 18;9(1):1546. doi: 10.1038/s41467-018-03947-w.

8.

A new surgical approach for punctal occlusion using fibrous tissue from under the lacrimal caruncle.

Yokoi N, Komuro A, Sotozono C, Kinoshita S.

Clin Ophthalmol. 2018 Mar 6;12:463-472. doi: 10.2147/OPTH.S155209. eCollection 2018.

9.

Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye.

Vu CHV, Kawashima M, Yamada M, Suwaki K, Uchino M, Shigeyasu C, Hiratsuka Y, Yokoi N, Tsubota K; Dry Eye Cross-Sectional Study in Japan Study Group.

Ophthalmology. 2018 Aug;125(8):1181-1188. doi: 10.1016/j.ophtha.2018.01.025. Epub 2018 Feb 16.

PMID:
29459039
10.

Ocular-muscle surgery for filamentary keratitis that developed in double elevator palsy.

Hieda O, Yokoi N, Sotozono C.

Int Med Case Rep J. 2017 Dec 4;10:385-388. doi: 10.2147/IMCRJ.S128964. eCollection 2017.

11.

Structure-function relationship of tear film lipid layer: A contemporary perspective.

Georgiev GA, Eftimov P, Yokoi N.

Exp Eye Res. 2017 Oct;163:17-28. doi: 10.1016/j.exer.2017.03.013. Review.

PMID:
28950936
12.

Severe Corneal Disorders Developed After Brimonidine Tartrate Ophthalmic Solution Use.

Maruyama Y, Ikeda Y, Yokoi N, Mori K, Kato H, Ueno M, Kinoshita S, Sotozono C.

Cornea. 2017 Dec;36(12):1567-1569. doi: 10.1097/ICO.0000000000001370.

PMID:
28938378
13.

Neurobiology of autoimmune encephalitis.

Fukata M, Yokoi N, Fukata Y.

Curr Opin Neurobiol. 2018 Feb;48:1-8. doi: 10.1016/j.conb.2017.07.012. Epub 2017 Aug 19. Review.

PMID:
28829986
14.

TFOS DEWS II pathophysiology report.

Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA.

Ocul Surf. 2017 Jul;15(3):438-510. doi: 10.1016/j.jtos.2017.05.011. Epub 2017 Jul 20. Review.

PMID:
28736340
15.

Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model.

Sugita J, Asada Y, Ishida W, Iwamoto S, Sudo K, Suto H, Matsunaga T, Fukuda K, Fukushima A, Yokoi N, Ohno T, Azuma M, Ebihara N, Saito H, Kubo M, Nakae S, Matsuda A.

Immun Inflamm Dis. 2017 Dec;5(4):515-525. doi: 10.1002/iid3.189. Epub 2017 Jul 20.

16.

Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds.

Georgiev GA, Yokoi N, Nencheva Y, Peev N, Daull P.

Int J Mol Sci. 2017 Jul 18;18(7). pii: E1558. doi: 10.3390/ijms18071558.

17.

Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry Eye.

Yokoi N, Georgiev GA, Kato H, Komuro A, Sonomura Y, Sotozono C, Tsubota K, Kinoshita S.

Am J Ophthalmol. 2017 Aug;180:72-85. doi: 10.1016/j.ajo.2017.05.022. Epub 2017 Jun 1.

PMID:
28579061
18.
19.

A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan.

Kawashima M, Yamada M, Suwaki K, Shigeyasu C, Uchino M, Hiratsuka Y, Yokoi N, Tsubota K; DECS-J Study Group.

Adv Ther. 2017 Mar;34(3):732-743. doi: 10.1007/s12325-017-0487-x. Epub 2017 Feb 8.

PMID:
28181147
20.

Meibomian Gland Physiology in Pre- and Postmenopausal Women.

Suzuki T, Minami Y, Komuro A, Yokoi N, Kinoshita S.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):763-771. doi: 10.1167/iovs.16-20811.

PMID:
28146241

Supplemental Content

Loading ...
Support Center